RAJAF · TFA Therapeutics, Inc.
Market Cap
$1.02B
Shares
111.12M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-09-02 | — | |
| 6-K | 2026-07-27 | — | |
| 6-K | 2026-06-25 | — | |
| 20-F | 2026-05-15 | 2025-12-31 | |
| 6-K | 2025-11-26 | 2025-11-25 | |
| 20-F/A | 2025-09-23 | 2023-12-31 | |
| 20-F | 2025-06-13 | 2024-12-31 | |
| 6-K | 2024-12-06 | — | |
| 20-F/A | 2024-10-28 | 2023-12-31 | |
| 20-F | 2024-07-05 | 2023-12-31 | |
| 6-K | 2024-03-19 | 2024-03-18 | |
| 6-K | 2023-11-13 | 2023-09-30 | |
| 6-K | 2023-09-28 | — | |
| 20-F | 2023-05-15 | 2022-12-31 |
Showing 1–14 of 14 filings